D.E. Shaw & Co
FATE icon

D.E. Shaw & Co’s Fate Therapeutics FATE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-433,192
Closed -$342K 3184
2025
Q1
$342K Sell
433,192
-1,103,441
-72% -$872K ﹤0.01% 2606
2024
Q4
$2.54M Sell
1,536,633
-1,841,017
-55% -$3.04M ﹤0.01% 1674
2024
Q3
$11.8M Sell
3,377,650
-700,272
-17% -$2.45M 0.01% 874
2024
Q2
$13.4M Buy
4,077,922
+1,346,956
+49% +$4.42M 0.01% 769
2024
Q1
$20M Sell
2,730,966
-851,013
-24% -$6.25M 0.02% 591
2023
Q4
$13.4M Sell
3,581,979
-1,129,685
-24% -$4.23M 0.01% 733
2023
Q3
$9.99M Buy
4,711,664
+112,225
+2% +$238K 0.01% 831
2023
Q2
$21.9M Buy
4,599,439
+1,634,197
+55% +$7.78M 0.02% 524
2023
Q1
$16.9M Buy
2,965,242
+2,707,319
+1,050% +$15.4M 0.02% 668
2022
Q4
$2.6M Buy
+257,923
New +$2.6M ﹤0.01% 1876
2022
Q2
Hold
0
4220
2022
Q1
Hold
0
4317
2021
Q4
Sell
-17,821
Closed -$1.06M 4047
2021
Q3
$1.06M Sell
17,821
-65,727
-79% -$3.89M ﹤0.01% 2458
2021
Q2
$7.25M Sell
83,548
-222,690
-73% -$19.3M 0.01% 1236
2021
Q1
$25.2M Sell
306,238
-89,919
-23% -$7.41M 0.02% 605
2020
Q4
$36M Sell
396,157
-130,170
-25% -$11.8M 0.03% 462
2020
Q3
$21M Buy
526,327
+75,367
+17% +$3.01M 0.02% 593
2020
Q2
$15.5M Buy
450,960
+29,759
+7% +$1.02M 0.02% 682
2020
Q1
$9.36M Buy
421,201
+314,949
+296% +$7M 0.01% 783
2019
Q4
$2.08M Buy
+106,252
New +$2.08M ﹤0.01% 1585
2019
Q3
Sell
-13,322
Closed -$270K 2616
2019
Q2
$270K Buy
+13,322
New +$270K ﹤0.01% 2335
2018
Q2
Sell
-36,796
Closed -$359K 2607
2018
Q1
$359K Buy
+36,796
New +$359K ﹤0.01% 2181